JUVENILE MACULAR DEGENERATION
Clinical trials for JUVENILE MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new JUVENILE MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for JUVENILE MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to halt blinding eye disease
Disease control Recruiting nowThis early study tests a new gene therapy called ACDN-01 for people with Stargardt disease, a genetic condition that leads to progressive vision loss. The therapy is given as a one-time injection under the retina. The main goals are to check safety and find the right dose, with a…
Matched conditions: JUVENILE MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Zapping the brain may help people with macular degeneration read better
Symptom relief Recruiting nowThis study tests whether a gentle electrical brain stimulation, called a-tDCS, can make reading training more effective for people with age-related or juvenile macular degeneration. About 30 participants will do six reading training sessions while receiving either real or fake st…
Matched conditions: JUVENILE MACULAR DEGENERATION
Phase: NA • Sponsor: University of Waterloo • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Thousands join fight against blindness by sharing their stories
Knowledge-focused Recruiting nowThis registry collects information from people with inherited retinal diseases, like retinitis pigmentosa and Stargardt disease. Participants share their symptoms, family history, and genetic test results online. The goal is to help researchers understand these rare diseases and …
Matched conditions: JUVENILE MACULAR DEGENERATION
Sponsor: Foundation Fighting Blindness • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study seeks volunteers for future eye disease treatment
Knowledge-focused Recruiting nowThis prescreening study aims to identify up to 50 people with ABCA4-related retinopathy, including Stargardt disease, for possible participation in future ACDN-01 clinical trials. Participants will undergo genetic testing and various eye exams to confirm their condition. This is …
Matched conditions: JUVENILE MACULAR DEGENERATION
Sponsor: Ascidian Therapeutics, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC